BESSOR PROJECT PIPELINE
Working with our academic partners, Bessor has built an initial portfolio of innovative projects across multiple indications in the areas of inflammation and cancer/immuno-oncology. The company is also advancing a platform technology based on mesynchmal stem cells and stem cell signaling molecules.
|Renalase agonists||Acute pancreatitis/Acute kidney injury (AKI)|
|TSG-6||Ocular inflammatory conditions, (Dry eye, corneal injury)|
|Anti-renalase antibodies||Pancreatic Cancer, melanoma, other tumors|
|Renalase agonists||Reversal of chemotherapy tissue damage cisplatin kidney toxicity treatment|
|Stem Cell Platform Technology|
|(mesynchymal stem cells, TSG-6)||Traumatic brain injury/concussion, periodontal disease, cardiovascular disease, ocular inflammatory conditions, (Dry eye, corneal injury)|